Henan Lingrui Pharmaceutical Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Wei Xiong
Chief Executive Officer (CEO)
CN¥1.8m
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 1.5yrs |
| Participación del CEO | 0.6% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | sin datos |
Actualizaciones recientes de la dirección
Recent updates
An Intrinsic Calculation For Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Suggests It's 44% Undervalued
Oct 28
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Surges 33% Yet Its Low P/E Is No Reason For Excitement
Oct 13If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity
Aug 07A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)
Jul 03Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market
May 07Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point
May 02Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%
Mar 04Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?
Feb 29CEO
Wei Xiong (39 yo)
1.5yrs
Permanencia
CN¥1,804,900
Compensación
Mr. Wei Xiong serves as General Manager and Chairman at Henan Lingrui Pharmaceutical Co. Ltd. since May 18, 2023 and served as its Managing Director.